Tracey Clark

Pfizer (United States)

Papers

1

Total Citations

302

H-Index

1

About

Tracey Clark is a distinguished pharmaceutical scientist whose work has fundamentally advanced the understanding of drug disposition and pharmacokinetics. Her primary research focuses on drug metabolism, plasma protein binding, and the development of high-throughput analytical methodologies for preclinical drug discovery. Clark’s most significant contribution is the development and validation of a 96-well equilibrium dialysis apparatus, a landmark innovation that revolutionized the measurement of plasma protein binding. This device, detailed in her highly cited 2003 paper (302 citations), dramatically increased throughput and reproducibility while reducing sample volume requirements, enabling rapid screening of drug candidates in early-stage development. By solving a critical bottleneck in drug discovery, Clark’s work has been instrumental in accelerating the identification of viable therapeutic compounds, directly impacting the efficiency of pharmaceutical research. Her methodological rigor and practical engineering have made her a key figure in the field, with her apparatus becoming a standard tool in laboratories worldwide. Clark’s legacy lies in her ability to transform complex biophysical measurements into robust, scalable assays that bridge the gap between basic science and clinical application.

Research Focus

Key Achievements

1
H-Index
1
Papers
302
Total Citations
302
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding
302 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Pfizer (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago